Data / Form D filings / Iris&Romeo, Inc.
Iris&Romeo, Inc.: Form D filings
Iris&Romeo, Inc., a company in San Francisco, CA, filed 3 Form D notices with the SEC between 2018 and 2023. The latest, on November 13, 2023, reports $3 million sold of a $3 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2261 MARKET STREET #4583, San Francisco, CA, 94114
- Phone
- (412) 370-0553
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1734344
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2023 | Amendment | $2,999,998 | $2,999,998 | 3 | Nov 6, 2023 | sec.gov | |
| Nov 13, 2023 | New notice | $5,087,182 | $5,087,182 | 16 | Nov 6, 2023 | sec.gov | |
| Mar 13, 2018 | New notice | $1,000,000 | $291,362 | $708,638 | 12 | Dec 1, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michele Gough-Baril | Executive Officer, Director | |
| Andrew Black | Director | |
| Cristina Nunez | Director | |
| Tara Desai | Executive Officer, Director |
Other companies in California that filed recently
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
- Series 23-1, a series of StartEngine Private Funds LLC $314,025 · Oct 30, 2026
- Omnissa Holdco LLC offering · Oct 30, 2026
- Angle Health, Inc. $591.5 million · Oct 29, 2026
- Agilis Medical, Inc. $4 million · Oct 28, 2026
- Bridgeview Innovations, Inc. $10.3 million · Oct 28, 2026
Every Form D from the week of Nov 13, 2023 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what Iris&Romeo, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.